The Australian Government's Science, Research and Innovation (SRI) Budget Tables show that overall investment in research and development is continuing to fall.
The USA's targeting of so-called 'foreign free-riding' in trade deals could lead to a poor deal on pharmaceuticals for the UK post-Brexit.
Gene therapies stand to benefit patients immensely, but there are questions about their commercial viability for pharmaceutical companies.
Although some malicious applications of synthetic biology may not seem plausible right now, they could become achievable with future advances.
A national survey has revealed that female scientists are not getting the same opportunities for promotion or seniority as their male peers with similar qualifications and experience.
Australia's future is at risk as performance declines amongst our maths and science students, says Science & Technology Australia (STA).
A new report has revealed favourable insights into clinical trials in Australia, where more than $1 billion is invested each year by both government and industry.
The overall market value of in vitro diagnostics stands at US$52 billion this year and is projected to grow at a compound annual growth rate of 4.2% to US$69 billion in 2024, according to GlobalData.
More than half (60%) of antibiotics given to patients after surgery to prevent infections are prescribed inappropriately, usually because they are not required at all — a situation that may be contributing to the rise of antibiotic resistance.
The Australian Research Council has announced its selection of Clarivate Analytics to provide citation information for the 2018 round of Excellence in Research for Australia (ERA), Australia's national research evaluation framework.
Innovation and Science Australia has released the 2030 Strategic Plan Issues Paper as part of its plan to drive the national conversation around the future of Australian innovation, science and research.
Arthur Sinodinos has unveiled the National Science Statement, articulating the government's vision and objectives for Australian science.
Innovation and Science Australia (ISA) Chair Bill Ferris has identified the six key innovation challenges Australia must address in order to become a top-tier innovation nation.
The world biosurgery market is expected to reach almost $12.76 billion by 2022 with a CAGR of 8.1% from 2015 to 2022, according to a report by Allied Market Research.
Bill Ferris AC has told Australia's university leaders that increasing collaboration for commercialisation of research is both desirable and achievable.